Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation

Annals of Surgical Oncology

Volumn 15, Issue 5, 2008, Pages 1316-1321

  Gimbergues, P ^a   Abrial, C ^a   Durando, X ^a   Bouedec, G Le ^a   Cachin, F ^a   Penault Llorca, F ^a   Mouret Reynier, M A ^a   Kwiatkowski, F ^a   Maublant, J ^a   Tchirkov, A ^a,b   Dauplat, J ^a  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Breast cancer Sentinel lymph node biopsy Neoadjuvant chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SIZE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; HUMAN; ISOTOPE LABELING; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM COMPOUNDS; TIN COMPOUNDS;

EID: 41649117974     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9759-z     Document Type: Article

References (39)

1. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-8
2. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-amulticenter validation study. N Engl J Med 1998; 339:941-6
3. Gordon F, Schwartz MD, MBA, Armando E, Giuliano MD, Umberto Veronesi MD. and the concensus conference committee. Human Pathology 2002; 6:579-89
4. Schwartz GF, Giuliano AE, Veronesi U. and the Concensus Conference Committee. Proceedings of the concensus conference on the role of sentinel node biopsy in carcinoma of the breast. Breast J 2002; 8:126-38
5. Bonadonna G, Valagussa P, Brambilla C, et al. Primary chemotherapy in operable breast cancer: eight year experience at the Milan Cancer Institute. J Clin Oncol 1998; 16:93-100
6. Cohen LF, Breslin TM, Kuerer HM, et al. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 2000; 24:1266-72
7. Nason KS, Anderson BO, Byrd DR, et al. Increased false-negative sentinzl node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000; 89:2187-94
8. Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000; 18:3480-6
9. Fernandez A, Cortes M, Benito E, et al. Gamma probe sentinel node localization and biopsy in breast cancer patients trated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 2001; 22:361-6
10. Stearns V, Ewing CA, Slack R, et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002; 9:235-42
11. Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 2001; 182:312-5
12. Schwartz GF, Meltzer AJ. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of breast. Breast J 2003; 9:374-9
13. Lang JE, Essermann LJ, Ewing CA, et al. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg 2004; 199:855-62
14. Shimazu K, Tamaki Y, Taguchi T, et al. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer 2004;100:2555-61
15. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005; 23:7703-20
16. Kuerer HM, Hunt KK. The rationale for integration of lymphatic mapping and sentinel node biopsy in the management of breast cancer patients receiving neoadjuvant chemotherapy. Semin Breast Dis 2002; 5:80-7
17. Sharkey FE, Addington SL, Fowler LJ, et al. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 1996; 9:893-900
18. Kang SH, Kim SK, Kwon Y, et al. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg 2004; 28:1019-24
19. Miller AR, Thomason VE, Yeh IT, et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol 2002; 9:243-7
20. Haid A, Tausch C, Lang A, et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001; 92:1080-4
21. Julian TB, Dusi D, Wolmark N. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2002; 184:315-7
22. Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 2002; 8:97-100
23. Balch GC, Mithani SK, Rchards KR, et al. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 2003; 10:616-21
24. Mamounas EP. Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am 2003; 83:931-42
25. Piato JR, Barros AC, Pincerato KM, et al. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 2003; 29:118-20
26. Xin Y, Foy M, Cox DD, et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006; 93:539-46
27. Fraile M, Rull M, Julian FJ, et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 2000; 11:701-5
28. Miltenburg DM, Miller C, Karamlou TB, et al. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999; 84:138-42
29. Kim T, Agboola O, Lyman GH. Lymphatic mapping and sentinel lymph node sampling in breast cancer: a meta-analysis. 2002 ASCO Annual Meeting Proceedings Orlando, FL, 2002. Available: http://www.asco.org/ac/11,1003,-12-002643-00-18- 0016-00-19-00139,00.asp
30. Jones JL, Zabicki K, Christian RL, et al. A comparaison of sentinel lymph node biopsy before and after neoadjuvant chemotherapy; timing is important. Am J Surg 2005;190:517-20
31. Cox CE, Cox JM, White LB, et al. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Ann Surg Oncol 2006; 13:483-90
32. Kinoshita T, TagasugiM, Iwamoto E, et al. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Am J Surg 2006; 191:225-9
33. Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27. J Clin Oncol 2005; 23:2694-702
34. Schrenk P, Huchreiner G, Fridik M. Sentinel node biopsy before preoperative chemotherapy for axillary lymph node staging in breast cancer. Breast J 2003;9:282-7
35. Ollila DW, Neuman HB, Sartor C, et al. Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers. Am J Surg 2005;190:371-5
36. Chung MH, Ye W, Giuliano AE. Role of sentinel lymph node dissection in the management of large (>5 cm) ivasive breast cancer. Ann Surg Oncol 2001; 8:688-92.
37. Lelievre L, Houvenaeghel G, Buttarelli M, et al. Value of the sentinel lymph node procedure in patient with large size breast cancer cancer. Ann Surg Oncol 2006; 14:621-6
38. Bredosian I, Reynolds C, Mick R, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 200; 88:2540-5
39. Mullan MH, Deacock SJ, Quiney NF, Kissin MW. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 2001; 27:218-9